ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,600,000 | -22.7% | 178,000 | -11.4% | 0.63% | -41.6% |
| Q2 2021 | $13,708,000 | -7.7% | 201,000 | -6.1% | 1.08% | -16.2% |
| Q1 2021 | $14,850,000 | -12.0% | 214,000 | -2.6% | 1.29% | -2.5% |
| Q4 2020 | $16,879,000 | -18.1% | 219,700 | -20.3% | 1.32% | -21.7% |
| Q3 2020 | $20,619,000 | +53.1% | 275,700 | +28.8% | 1.69% | -3.0% |
| Q2 2020 | $13,471,000 | +106.9% | 214,000 | +38.1% | 1.74% | +39.5% |
| Q1 2020 | $6,510,000 | -11.5% | 155,000 | -4.3% | 1.25% | -12.2% |
| Q4 2019 | $7,358,000 | -27.3% | 162,000 | -26.7% | 1.42% | -33.3% |
| Q3 2019 | $10,115,000 | -25.0% | 221,000 | -3.9% | 2.13% | -19.6% |
| Q2 2019 | $13,485,000 | +54.3% | 230,000 | +17.9% | 2.65% | +49.2% |
| Q1 2019 | $8,742,000 | +24.7% | 195,000 | +8.3% | 1.78% | -14.0% |
| Q4 2018 | $7,011,000 | -25.7% | 180,000 | -12.2% | 2.06% | +22.0% |
| Q3 2018 | $9,435,000 | +3.7% | 205,000 | -1.8% | 1.69% | -3.3% |
| Q2 2018 | $9,099,000 | +77.2% | 208,700 | +60.5% | 1.75% | -0.5% |
| Q1 2018 | $5,135,000 | -11.1% | 130,000 | -23.5% | 1.76% | -21.2% |
| Q4 2017 | $5,774,000 | +85.6% | 170,000 | +39.3% | 2.23% | +149.7% |
| Q3 2017 | $3,111,000 | – | 122,000 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
| Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
| DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
| PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
| Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
| Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
| Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
| EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |